Buzurovic Ivan M, O'Farrell Desmond A, Harris Thomas C, Friesen Scott, King Martin T, Cormack Robert A, Devlin Phillip M
Department of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
J Contemp Brachytherapy. 2021 Apr;13(2):195-204. doi: 10.5114/jcb.2021.105288. Epub 2021 Apr 14.
High-dose-rate (HDR) brachytherapy is an alternative treatment to electron external beam radiation therapy (EBRT) of superficial skin lesions. The purpose of this study was to establish the selection criteria for HDR brachytherapy technique (HDR-BT) and EBRT in cutaneous oncology for various clinical scenarios.
The study consists of two parts: a) EBRT and HDR-BT treatment plans comparison analyzing clinical target volumes (CTVs) with different geometries, field sizes, and topologies, and b) development of a prediction model capable of characterization of dose distributions in HDR surface brachytherapy for various geometries of treatment sites.
A loss of CTV coverage for the electron plans (D, D) was recorded up to 45%, when curvature of the applicator increased over 30°. Values for D2 cm for both plans were comparable, and they were in range of ±8% of prescription dose. An increase in higher doses (D0.5 cm and D0.1 cm) was observed in HDR-BT plans, and it was greater for larger lesions. The average increase was 3.8% for D0.5 cm and 12.3% for D0.1 cm. When CTV was approximately flat, electron plans were comparable with HDR-BT plans, having lower average D2 cm, D0.5 cm, and D0.1 cm of 7.7%. Degradation of quality of electron plans was found to be more dependent on target curvature than on CTV size.
Both EBRT and HDR-BT could be used in treatments of superficial lesions. HDR-BT revealed superior CTV coverage when the surface was very large, complex, curvy, or rounded, and when the topology was complicated. The prediction model can be used for an approximate calculation and quick assessment of radiation dose to organs-at-risk (OARs), at a depth or at a lateral distance from CTV.
高剂量率(HDR)近距离放射治疗是浅表皮肤病变电子外照射放疗(EBRT)的一种替代治疗方法。本研究的目的是为皮肤肿瘤学中各种临床情况建立HDR近距离放射治疗技术(HDR-BT)和EBRT的选择标准。
本研究包括两个部分:a)EBRT和HDR-BT治疗计划比较,分析具有不同几何形状、射野大小和拓扑结构的临床靶区(CTV),b)开发一种预测模型,能够表征不同治疗部位几何形状的HDR表面近距离放射治疗中的剂量分布。
当施源器曲率增加超过30°时,电子计划的CTV覆盖损失(D、D)高达45%。两种计划的D2 cm值相当,在处方剂量的±8%范围内。在HDR-BT计划中观察到较高剂量(D0.5 cm和D0.1 cm)增加,较大病变增加更大。D0.5 cm平均增加3.8%,D0.1 cm平均增加12.3%。当CTV大致平坦时,电子计划与HDR-BT计划相当,平均D2 cm、D0.5 cm和D0.1 cm低7.7%。发现电子计划质量的下降更多地取决于靶区曲率而非CTV大小。
EBRT和HDR-BT均可用于浅表病变的治疗。当表面非常大、复杂、弯曲或圆形,以及拓扑结构复杂时,HDR-BT显示出更好的CTV覆盖。该预测模型可用于近似计算和快速评估距CTV深度或横向距离处的危及器官(OAR)的辐射剂量。